Impact of natural IgM concentration on gene therapy with adenovirus type 5 vectors

Journal of Virology

Volumn 89, Issue 6, 2015, Pages 3412-3416

  Qiu, Qi ^a   Xu, Zhili ^a   Tian, Jie ^a   Moitra, Rituparna ^a   Gunti, Sreenivasulu ^b   Notkins, Abner L ^b   Byrnes, Andrew P ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; IMMUNOGLOBULIN M;

AFFINITY CHROMATOGRAPHY; ALLELE; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE LOCUS; HUMAN ADENOVIRUS 5; IGH 6 GENE; IN VIVO STUDY; KUPFFER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS GENE; VIRUS STRAIN; ADENOVIRIDAE; ANIMAL; BAGG ALBINO MOUSE; BLOOD; C57BL MOUSE; GENE THERAPY; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; KNOCKOUT MOUSE; LIVER; PHYSIOLOGY; VIROLOGY;

HUMAN ADENOVIRUS TYPE 5; MUS;

ADENOVIRIDAE; ANIMALS; GENETIC THERAPY; GENETIC VECTORS; IMMUNOGLOBULIN M; LIVER; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; TRANSDUCTION, GENETIC;

EID: 84923198043     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03217-14     Document Type: Article

References (28)

1. Lopez-Gordo E, Denby L, Nicklin SA, Baker AH. 18 July 2014, posting date. The importance of coagulation factors binding to adenovirus: historical perspectives and implications for gene delivery. Expert Opin Drug Deliv http://dx.doi.org/10.1517/17425247.2014.938637.
2. Xu Z, Tian J, Smith JS, Byrnes AP. 2008. Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies and complement. J Virol 82:11705-11713. http://dx.doi.org/10.1128/JVI.01320-08.
3. Kalyuzhniy O, Di Paolo NC, Silvestry M, Hofherr SE, Barry MA, Stewart PL, Shayakhmetov DM. 2008. Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo. Proc Natl Acad Sci U S A 105:5483-5488. http://dx.doi.org/10.1073/pnas.0711757105.
4. Vigant F, Descamps D, Jullienne B, Esselin S, Connault E, Opolon P, Tordjmann T, Vigne E, Perricaudet M, Benihoud K. 2008. Substitution of hexon hypervariable region 5 of adenovirus serotype 5 abrogates blood factor binding and limits gene transfer to liver. Mol Ther 16:1474-1480. http://dx.doi.org/10.1038/mt.2008.132.
5. Waddington SN, McVey JH, Bhella D, Parker AL, Barker K, Atoda H, Pink R, Buckley SM, Greig JA, Denby L, Custers J, Morita T, Francischetti IM, Monteiro RQ, Barouch DH, van Rooijen N, Napoli C, Havenga MJ, Nicklin SA, Baker AH. 2008. Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 132:397-409. http://dx.doi.org/10.1016/j.cell.2008.01.016.
6. Racine R, Winslow GM. 2009. IgM in microbial infections: taken for granted?ImmunolLett 125:79-85. http://dx.doi.org/10.1016/j.imlet.2009.06 .003.
7. Ehrenstein MR, Notley CA. 2010. The importance of natural IgM: scavenger, protector and regulator. Nat Rev Immunol 10:778-786. http://dx .doi.org/10.1038/nri2849.
8. Xu Z, Qiu Q, Tian J, Smith JS, Conenello GM, Morita T, Byrnes AP. 2013. Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement. Nat Med 19:452-457. http://dx.doi.org/10.1038/nm.3107.
9. Khare R, Hillestad ML, Xu Z, Byrnes AP, Barry MA. 2013. Circulating antibodies and macrophages as modulators of adenovirus pharmacology. J Virol 87:3678-3686. http://dx.doi.org/10.1128/JVI.01392-12.
10. Unzu C, Melero I, Morales-Kastresana A, Sampedro A, Serrano-Mendioroz I, Azpilikueta A, Ochoa MC, Dubrot J, Martinez-Anso E, Fontanellas A. 2014. Innate functions of immunoglobulin M lessen liver gene transfer with helper-dependent adenovirus. PLoS One 9:e85432. http://dx.doi.org/10.1371/journal.pone.0085432.
11. Wolff G, Worgall S, van Rooijen N, Song WR, Harvey BG, Crystal RG. 1997. Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ. J Virol 71:624-629.
12. Alemany R, Suzuki K, Curiel DT. 2000. Blood clearance rates of adenovirus type 5 in mice. J Gen Virol 81:2605-2609.
13. Tao N, Gao GP, Parr M, Johnston J, Baradet T, Wilson JM, Barsoum J, Fawell SE. 2001. Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver. Mol Ther 3:28-35. http://dx.doi.org/10.1006/mthe.2000.0227.
14. Snoeys J, Mertens G, Lievens J, van Berkel T, Collen D, Biessen EA, De Geest B. 2006. Lipid emulsions potently increase transgene expression in hepatocytes after adenoviral transfer. Mol Ther 13:98-107. http://dx.doi .org/10.1016/j.ymthe.2005.06.477.
15. Manickan E, Smith JS, Tian J, Eggerman TL, Lozier JN, Muller J, Byrnes AP. 2006. Rapid Kupffer cell death after intravenous injection of adenovirus vectors. Mol Ther 13:108-117. http://dx.doi.org/10.1016/j .ymthe.2005.08.007.
16. Côrte-Real J, Rodo J, Almeida P, Garcia J, Coutinho A, Demengeot J, Penha-Gonçalves C. 2009. Irf4 is a positional and functional candidate gene for the control of serum IgM levels in the mouse. Genes Immun 10:93-99. http://dx.doi.org/10.1038/gene.2008.73.
17. Rozing J, Brons NH, Benner R. 1978. Effects of splenectomy on the humoral immune system. A study in neonatally and adult splenectomized mice. Immunology 34:909-917.
18. Wardemann H, Boehm T, Dear N, Carsetti R. 2002. B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen. J Exp Med 195:771-780. http://dx.doi.org/10.1084/jem.20011140.
19. Notkins AL. 2004. Polyreactivity of antibody molecules. Trends Immunol 25:174-179. http://dx.doi.org/10.1016/j.it.2004.02.004.
20. Zhou ZH, Tzioufas AG, Notkins AL. 2007. Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells. J Autoimmun 29:219-228. http://dx.doi.org/10.1016/j.jaut.2007.07.015.
21. Zhou ZH, Zhang Y, Hu YF, Wahl LM, Cisar JO, Notkins AL. 2007. The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies. Cell Host Microbe 1:51-61. http://dx.doi.org/10 .1016/j.chom.2007.01.002.
22. Wands JR, Zurawski VR, Jr. June 1981. Process for producing antibodies to hepatitis virus and cell lines therefor. US Patent 4,271,145.
23. Rickert RC, Rajewsky K, Roes J. 1995. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376:352-355. http://dx.doi.org/10.1038/376352a0.
24. Pao LI, Lam KP, Henderson JM, Kutok JL, Alimzhanov M, Nitschke L, Thomas ML, Neel BG, Rajewsky K. 2007. B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity. Immunity 27:35-48. http://dx.doi.org/10 .1016/j.immuni.2007.04.016.
25. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68:869-877. http://dx.doi.org/10.1016/0092-8674(92)90030-G.
26. Stall AM, Loken MR. 1984. Allotypic specificities of murine IgD and IgM recognized by monoclonal antibodies. J Immunol 132:787-795.
27. Schreier PH, Quester S, Bothwell A. 1986. Allotypic differences in murinemugenes. Nucleic Acids Res 14:2381-2389. http://dx.doi.org/10.1093/nar/14.5.2381.
28. Tian J, Xu Z, Smith JS, Hofherr SE, Barry MA, Byrnes AP. 2009. Adenovirus activates complement by distinctly different mechanisms in vitro and in vivo: indirect complement activation by virions in vivo. J Virol 83:5648-5658. http://dx.doi.org/10.1128/JVI.00082-09.